EIS Organising Committee
Prof. Anat Loewenstein
President
EURETINA
Dr. Kourous Rezaei
Co-opted Board Member
EURETINA
PROF. Martin Zinkernagel
General Secretary
EURETINA
Prof. Nicole Eter
PRESIDENT ELECT
EURETINA
Mr. Alistair Laidlaw
Past President
EURETINA
DARA CONLON
EXECUTIVE VICE-PRESIDENT
EURETINA
Contributors
Euretina is delighted to announce the following speakers and panellists confirmed to participate in the EURETINA Innovation Spotlight (EIS) taking place on the 18th September 2024 at the CCIB Barcelona, preceding the EURETINA Annual Congress.
Sharon Bakalash
Global Head, Medical Affairs
ASTELLAS
Dr. Remko Bakker
Global Head Research Retinal Health
BOEHRINGER INGELHEIM
Prof. Francesco Bandallo MD
University Vita-Salute Ospedale San Raffaele
ITALY
Dr. Sam Barone
CMO
NANOSCOPE THERAPEUTICS
Mr. Pierre Billardon
CEO
DUTCH OPHTHALMIC RESEARCH CENTRE
Carlos Ciller
Co-Founder & CEO
RETINAI
Brad Doerschuk
PRESIDENT & CEO
INFOCUS CLINICAL RESEARCH
Mr. Sascha Fauser
Global Head of Ophthalmology
ROCHE
Dr. Cedric Francois
President & CEO
APELLIS PHARMACEUTICALS USA
Ms. Anta Gkelou
Principal, Capital Strategy
SOFINNOVA PARTNERS
Dr. Frederic Guerard
CEO
OPTHEA
Tarek Hassan
Chief Development Officer
AVICEDA
Frank Holz
University of Bonn
GERMANY
Ralf Hornig PhD.
Clinical Affairs Director
SCIENCE
Arshad Khanani
University of Nevada
USA
Dr. Robert Kim
Chief Medical Officer
4D MOLECULAR THERAPEUTICS
Jennifer Kissner
SVP CLINICAL DEVELOPMENT
OUTLOOK THERAPEUTICS
Dr. Sergio Leal
Director, Global Clinical Leader
BAYER
Dr. Stephanie Magazzeni
Head of Digital Research and Innovation
ZEISS
Dr. Helge Menz
Assistant to the General Manager
PHARMPUR GMBH
Mr. Kester Nahen
CEO
NOTAL VISION
Manuel Opitz
CO-FOUNDER & CEO
DEEPEYE MEDICAL GMBH
Grazia Pertile
Sacro Cuore Hospital
ITALY
Tunde Peto
Queens University Belfast
UK
Ramiro Ribeiro
Chief Medical Officer
EYEPOINT PHARMACEUTICALS
DR. Christian Roesky
CEO
NOVALIQ
Amir Sadeghipour
CTO & Co-Founder
RETINSIGHT
Star Seyedkazemi
Chief Development Officer
ADVERUM BIOTECH
DR. Riad Sherif
CEO
OCULIS
Julian Smith
General Manager, Global Commercial Development
ABBVIE
Derek Swan
CTO
OPTOS
Sumie Takahara
Executive Director
REGENXBIO
Kirsten Vonde
Executive Consultant
GRANZER REGULATORY CONSULTING & SERVICES GMBH
Stela VujoSevic
University of Milano
ITALY
Mr. Edward Van Wezel
Managing Partner
BIOGENERATION VENTURES
Bonnie van Wilgenburg
Principal
MONOGRAPH BIO
Nadia Waheed
Chief Medical Officer
OCULAR THERAPEUTIX
David Zacks
Executive Director
ONL THERAPEUTICS
| Dimitris Aktypis, Phaco & VR Marketing Senior Director, ALCON |
| Ioanna Psalti, EU EYE |
